IND for SON-1010 cleared by FDA with first affected person dosed in trial for superior stable tumors SON-080 on monitor to start scientific research by mid-2022 Preclinical…
- Monday, June 5, 2023
IND for SON-1010 cleared by FDA with first affected person dosed in trial for superior stable tumors SON-080 on monitor to start scientific research by mid-2022 Preclinical…